Skip to main content
. 2021 Mar 15;48(2):1137–1149. doi: 10.1007/s00068-021-01623-1

Fig. 3.

Fig. 3

Change in -FABP levels over time in patients with or without intra-abdominal hypertension (a, b) or new organ failure (c, d). Data are shown as median (P25P75) I-FABP levels, uncorrected (a, c) and corrected (b, d) for creatinine excretion. Creat, creatinine; IAH, intra-abdominal hypertension; I-FABP, intestinal fatty acid-binding protein